PCN34 BUDGET IMPACT ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) IN BRAZIL
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74285-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)74285-6/fulltext
Section Title :
Section Order :
211
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74285-6&doi=10.1016/S1098-3015(10)74285-6